Publisher
Springer Science and Business Media LLC
Reference114 articles.
1. US Food and Drug Administration (FDA). Facts about Generics. 2015. http://www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/understandinggenericdrugs/ucm167991.htm . Accessed 9 Sep 2017.
2. Bate R, Mathur A, Lever HM, Thakur D, Graedon J, Cooperman T, et al. Generics substitution, bioequivalence standards, and international oversight: complex issues facing the FDA. Trends Pharmacol Sci. 2016;37:184–91. https://doi.org/10.1016/j.tips.2015.11.005 .
3. Straka RJ, Keohane DJ, Liu LZ. Potential clinical and economic impact of switching branded medications to generics. Am J Ther. 2017;24:e278–89. https://doi.org/10.1097/MJT.0000000000000282 .
4. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25:2875–90.
5. Crawford P, Feely M, Guberman A, Kramer G. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Seizure. 2006;15:165–76. https://doi.org/10.1016/j.seizure.2005.12.010 .
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献